French Minister for the Economy, Finance and Industry Antoine Armand visits the Doliprane medication production site of French multinational pharmaceutical and healthcare company Sanofi, in Lisieux, northern France, on October 14, 2024. Sanofi said it entered into negotiations with US private equity firm Clayton Dubilier & Rice (CR&R) for the potential sale of a controlling 50 percent stake in its subsidiary Opella, which produces Doliprane, the best-selling drug in France. (Photo by LOU BENOIST / AFP) (Photo by LOU BENOIST/AFP via Getty Images)